Hamps Bio Limited , a prominent player in the biotech industry, has announced significant changes to its board composition and committee structure. The company has appointed Ms. Shivali Rajpurohit as an Additional Director in the category of Non-Executive Independent Director, effective August 25, 2025, subject to shareholder approval.

New Independent Director Appointment

Ms. Shivali Rajpurohit brings a wealth of experience to her new role at Hamps Bio Limited. She is a qualified Company Secretary with a degree in law (LL.B) and specializes in corporate laws, secretarial compliance, including Companies Act, SEBI Regulations, Legal Documentation, Regulatory Filings, and Governance Framework. With over two years of experience handling legal and secretarial matters for both listed and unlisted entities, Ms. Rajpurohit is well-equipped to contribute to the company's governance and compliance efforts.

The appointment is for a five-year term, commencing from August 25, 2025, pending approval from the company's shareholders. Ms. Rajpurohit is not related to any existing directors of Hamps Bio Limited and is not debarred from holding directorship positions by SEBI or any other authority.

Board Committee Reconstitution

Following Ms. Rajpurohit's appointment, Hamps Bio Limited has announced a significant reshuffle of its board committees:

Audit Committee

• Chairperson: Mr. Jinay Dipakkumar Palrecha (Independent Non-Executive Director)
• Members:
  • Ms. Shivali Rajpurohit (Independent Non-Executive Director)
  • Mrs. Pallavi Herrik Shah (Non-Executive Director)

Nomination and Remuneration Committee

• Chairperson: Ms. Shivali Rajpurohit (Independent Non-Executive Director)
• Members:
  • Mr. Jinay Dipakkumar Palrecha (Independent Non-Executive Director)
  • Mrs. Pallavi Herrik Shah (Non-Executive Director)

Stakeholders Relationship Committee

• Chairperson: Mrs. Pallavi Herrik Shah (Non-Executive Director)
• Members:
  • Mr. Jinay Dipakkumar Palrecha (Independent Non-Executive Director)
  • Ms. Shivali Rajpurohit (Independent Non-Executive Director)

These changes in the board composition and committee structure are aimed at enhancing the company's corporate governance practices and ensuring compliance with regulatory requirements.

The appointment of Ms. Rajpurohit and the reconstitution of board committees reflect Hamps Bio Limited's commitment to maintaining a strong and diverse leadership team. These strategic moves are expected to bring fresh perspectives and strengthen the company's decision-making processes in the dynamic biotech industry.

Hamps Bio Limited , a prominent player in the biotechnology sector, has made significant announcements following its recent board meeting. The company has approved a bonus share issue and set the date for its 18th Annual General Meeting (AGM), among other important decisions.

Bonus Share Issue

The board of Hamps Bio Limited has approved the issuance of bonus shares in a 1:1 ratio, subject to shareholder approval. This means that shareholders will receive one bonus equity share of Rs. 10 each for every fully paid-up equity share held. The bonus issue will be funded from the company's free reserves and securities premium account, which totaled Rs. 444.45 lakhs as of March 31, 2025.

Impact on Share Capital

The bonus issue will have a significant impact on the company's share capital structure:

The total number of new equity shares to be issued is approximately 43.56 lakh, with a total value of Rs. 435.60 lakhs.

Annual General Meeting

The board has set the date for the 18th Annual General Meeting (AGM) for August 29, 2025. The meeting will be held at 4:00 PM at the company's registered office in Ankleshwar, Gujarat.

Other Key Decisions

1. Increase in Authorized Share Capital: The board approved an increase in the authorized share capital of the company, with a consequential amendment to the Memorandum of Association.

2. Annual Report Approval: The draft annual report for the financial year ended March 31, 2025, has been approved.

3. Director Reappointment: Mr. Shrenikkumar Mountkumar Shah (DIN - 00973690), who retires by rotation, has been appointed for re-election.

4. Secretarial Audit: The board noted the Secretarial Audit report issued by M/S Richa Goyal & Associates for the financial year ended March 31, 2025.

5. AGM Scrutinizer: Mrs. Richa Manoj Goyal, a Practicing Company Secretary, has been appointed as the scrutinizer for the 18th AGM.

Timeline for Bonus Shares

The company expects to credit or dispatch the bonus shares within two months from the date of the board meeting, by September 28, 2025.

These developments signify Hamps Bio Limited's commitment to rewarding its shareholders and maintaining transparency in its corporate governance practices. Investors and stakeholders will be keenly watching the upcoming AGM for further insights into the company's performance and future strategies.